Ryan Spencer
CIK 1777938 · CEO and Director · last filed 2026-02-10
Ryan Spencer is a CEO and Director who has filed 25 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for DVAX, was dated Feb 10, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
25
-$1.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | CEO and Director | 136,000 | $15.50 | $2.11M | -$1.13M | 21 | 2026-02-10 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | — | $221.38 | — | $0 | 4 | 2026-01-07 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-10 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | −379,620 | $0 | EDGAR |
| 2026-01-07 | Cidara Therapeutics, Inc. (CDTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-12-29 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +118,415 | -$2.13M | EDGAR |
| 2025-06-18 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-02-20 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +18,472 | -$472.3K | EDGAR |
| 2025-02-18 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +30,806 | -$402.2K | EDGAR |
| 2025-02-12 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +9,624 | -$148.0K | EDGAR |
| 2024-07-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-30 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-20 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | +402 | $3.8K | EDGAR |